Two more minor league players have run afoul of baseball's drug prevention and treatment program, each earning 50-game suspensions after testing positive for banned substances.
Twins minor league catcher Michael Quesada batted .234/.329/.313 in 64 at-bats for Rookie-level Elizabethton this season prior to testing positive for Methylhexaneamine. Minnesota selected him from Sierra (Calif.) JC in the 24th round of the 2010 draft.
Released by the Giants on July 18, free agent third baseman John Eshleman tested positive for metabolites of Nandrolone (commonly sold as Deca-Durabolin) and will sit out 50 games without pay if and when he signs with another organization. He batted .211/.274/.246 in 57 at-bats for low Class A Augusta this season. Eshleman he joined the Giants as an 11th-round pick from Mount San Jacinto (Calif.) JC in 2009.